Inhibrx Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	153.09	152.6	277.92	273.87	131.3	128.66
Cash & Short-Term Investments	153.09	152.6	277.92	273.87	131.3	128.66
Cash Growth	-22.03%	-45.09%	1.48%	108.58%	2.05%	1014.94%
Accounts Receivable	0.11	0.36	0.78	0.24	0.37	0.08
Other Receivables	0.73	0.06	-	0.01	0.51	0.53
Total Trade Receivables	0.84	0.42	0.78	0.26	0.88	0.62
Other Current Assets	7.5	7.38	16.66	6.37	6.93	2.89
Total Current Assets	161.42	160.4	295.36	280.49	139.11	132.17
Net Property, Plant & Equipment	10.31	13.54	9.37	7.22	9.49	11.32
Other Long-Term Assets	5.74	6.83	3.16	3.16	1.85	0.25
Total Assets	177.47	180.77	307.89	290.88	150.45	143.74
Accounts Payable	6.77	9.25	10.95	8.33	-	13.46
Accrued Expenses	26.96	29.89	43.3	17.22	9.62	13.36
Current Portion of Leases	2.25	1.6	2.06	1.86	1.67	1.5
Unearned Revenue	-	-	-	0.17	2.03	3.08
Total Current Liabilities	35.98	40.73	56.31	27.58	22.45	31.4
Long-Term Debt	99.92	-	206.97	202.07	70.47	29.24
Long-Term Leases	4.74	6.45	1.11	3.17	5.03	6.71
Other Long-Term Liabilities	-	-	-	-	0.11	0.92
Total Long-Term Liabilities	104.66	6.45	208.08	205.24	75.61	36.87
Total Liabilities	140.64	47.18	264.39	232.82	98.07	68.27
Common Stock	0	0	0.01	0	0	0
Additional Paid-in Capital	250.18	239.72	657.23	430.43	279.53	220.85
Retained Earnings	-213.35	-106.13	-613.73	-372.37	-227.15	-145.38
Shareholders' Equity	36.83	133.58	43.5	58.06	52.38	75.47
Total Liabilities & Equity	177.47	180.77	307.89	290.88	150.45	143.74
Total Debt	106.91	8.05	210.14	207.1	77.18	37.45
Net Cash (Debt)	46.18	144.55	67.78	66.76	54.12	91.21
Net Cash Growth	-68.05%	113.25%	1.53%	23.35%	-40.66%	-
Net Cash Per Share	2.98	9.65	5.75	1.67	1.42	3.61
Book Value	36.83	133.58	43.5	58.06	52.38	75.47
Book Value Per Share	2.38	8.92	3.69	1.45	1.38	2.99
Tangible Book Value	36.83	133.58	43.5	58.06	52.38	75.47
Tangible Book Value Per Share	2.38	8.92	3.69	1.45	1.38	2.99

Updated Nov 14, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q